Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A WERNER

Showing results (1251-1260 of 1,356) with videos related to

Pageof 136
Sort By:
Theranostics|May 23, 2017
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachRudolf A Werner, Alexander Weich, Takahiro Higuchi, et al.
Muscle & Nerve|July 19, 2012
Evidence-based guideline: neuromuscular ultrasound for the diagnosis of carpal tunnel syndromeMichael S Cartwright, Lisa D Hobson-Webb, Andrea J Boon, et al.
Theranostics|January 7, 2020
<sup>18</sup>F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular ImagingRudolf A Werner, Thorsten Derlin, Constantin Lapa, et al.
Molecular Imaging and Biology|May 30, 2019
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [<sup>18</sup>F]DCFPyL: Impact of Tumor Burden on Normal Organ UptakeRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Oncotarget|October 6, 2016
Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneityRudolf A Werner, Constantin Lapa, Harun Ilhan, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine CarcinomasAlexander Weich, Rudolf A Werner, Andreas K Buck, et al.
The New England Journal of Medicine|September 11, 1997
Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial InvestigatorsM P Savage, J S Douglas, D L Fischman, et al.
Molecular Imaging and Biology|July 18, 2018
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide TherapyRudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 11, 2025
Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial MeningiomasRicarda Ebner, Jana Braach, Johannes Rübenthaler, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 27, 2012
Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinomaAntoine Digonnet, Marc Hamoir, Guy Andry, et al.
Pageof 136

Showing results (1251-1260 of 1,356) with videos related to

Sort By:
Pageof 136
Theranostics|May 23, 2017
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachRudolf A Werner, Alexander Weich, Takahiro Higuchi, et al.
Muscle & Nerve|July 19, 2012
Evidence-based guideline: neuromuscular ultrasound for the diagnosis of carpal tunnel syndromeMichael S Cartwright, Lisa D Hobson-Webb, Andrea J Boon, et al.
Theranostics|January 7, 2020
<sup>18</sup>F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular ImagingRudolf A Werner, Thorsten Derlin, Constantin Lapa, et al.
Molecular Imaging and Biology|May 30, 2019
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [<sup>18</sup>F]DCFPyL: Impact of Tumor Burden on Normal Organ UptakeRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Oncotarget|October 6, 2016
Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneityRudolf A Werner, Constantin Lapa, Harun Ilhan, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine CarcinomasAlexander Weich, Rudolf A Werner, Andreas K Buck, et al.
The New England Journal of Medicine|September 11, 1997
Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial InvestigatorsM P Savage, J S Douglas, D L Fischman, et al.
Molecular Imaging and Biology|July 18, 2018
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide TherapyRudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 11, 2025
Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial MeningiomasRicarda Ebner, Jana Braach, Johannes Rübenthaler, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 27, 2012
Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinomaAntoine Digonnet, Marc Hamoir, Guy Andry, et al.
Pageof 136